Alkermes outlined plans to move its NT1 drug candidate, alixorexton, into phase 3 after posting results from the midstage ...

Helen's husband Brent Arthur said: "We were told Helen had a brain tumour, which was a complete shock. The doctors said most ...

A mum-of-two died from an aggressive brain tumour after her back pain was initially diagnosed as a trapped nerve. Helen ...

Viatris reported that its MR-139 ophthalmic ointment failed to meet its primary endpoint in a Phase III blepharitis trial, while advancing its MR-141 and MR-142 candidates in presbyopia and night ...

A mum-of-two died from an aggressive brain tumour after her back pain was initially misdiagnosed as a trapped nerve. Helen Arthur, 57, first became unwell on Good Friday in April 2019, experiencing ...

VTRS slides after phase III trial failure for blepharitis drug MR-139, adding pressure to an already struggling stock.

For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical outcomes compared with conventional ...

Many common bedroom items can negatively impact sleep and well-being. Mold-prone plants, workout equipment, and dirty laundry ...

A GRAN passed away after her back pain was initially dismissed as a ‘trapped nerve’. Helen Arthur, 57, first became unwell on Good Friday in April 2019, experiencing persistent back ...

Viatris announces phase 3 study of MR-139 for blepharitis fails to meet its primary endpoint: Pittsburgh Monday, July 21, 2025, 11:00 Hrs [IST] Viatris Inc., a global healthcare c ...

Viatris’ investigational blepharitis ointment failed to achieve the primary endpoint in its Phase III trial, prompting the ...